308
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Serum 1,25(OH)2 Vitamin D and 25(OH) Vitamin D Ratio for the Diagnosis of Sarcoidosis-Related Uveitis

, , , ORCID Icon, , , , , , ORCID Icon, , & show all
Pages 341-347 | Received 08 Aug 2018, Accepted 15 Oct 2018, Published online: 05 Nov 2018

References

  • Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996 Sep;80(9):844–848. doi:10.1136/bjo.80.9.844.
  • Dick AD, Tundia N, Sorg R, et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmol. 2016 Mar 1;123(3):655–662. doi:10.1016/j.ophtha.2015.10.028.
  • Gritz DC, Schwaber EJ, Wong IG. Complications of uveitis: the northern California epidemiology of uveitis study. Ocul Immunol Inflamm. 2018; 26(4):584–594. doi:10.1080/09273948.2016.1247174. Epub 2017 Jan 23.
  • Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: results from the pacific ocular inflammation study. JAMA Ophthalmol. 2013 Nov 1;131(11):1405–1412. doi:10.1001/jamaophthalmol.2013.4237.
  • Albaroudi N, Tijani M, Boutimzine N, Cherkaoui O, Laghmari M. [Prognostic factors in uveitis]. J Fr Ophtalmol. 2017 Nov; 40(9):751–757. doi:10.1016/j.jfo.2017.04.005. Epub 2017 Sep 4.
  • Hadjadj J, Dechartres A, Chapron T, et al. Relevance of diagnostic investigations in patients with uveitis: retrospective cohort study on 300 patients. Autoimmun Rev. 2017 May;16(5):504–511. doi:10.1016/j.autrev.2017.03.006.
  • Koeffler HP, Reichel H, Bishop JE, Norman AW. gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun. 1985 Mar 15;127(2):596–603.
  • Burke RR, Rybicki BA, Rao DS. Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med. 2010 Aug;31(4):474–484. doi:10.1055/s-0030-1262215.
  • Kavathia D, Buckley JD, Rao D, Rybicki B, Burke R. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med. 2010 Apr;104(4):564–570. doi:10.1016/j.rmed.2009.12.004.
  • Trusko B, Thorne J, Jabs D, et al. The Standardization of Uveitis Nomenclature (SUN) project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med. 2013;52(3):259–65, S1-6. doi:10.3414/ME12-01-0063.
  • Abad S, Meyssonier V, Allali J, et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum. 2004 Dec 15;51(6):974–982. doi:10.1002/art.20683.
  • Herbort CP, Rao NA, Mochizuki M. Members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm.. 2009 Jun;17(3):160–169. doi:10.1080/09273940902818861.
  • Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008 Nov;146(5):772–779. doi:10.1016/j.ajo.2008.06.011.
  • Dougados M, van der Linden S, Juhlin R, et al. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991 Oct;34(10):1218–1227. doi:10.1002/art.1780341003.
  • Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965 Mar;31(122):552–568.
  • International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol JEADV. 2014 Mar;28(3):338–347. doi:10.1111/jdv.12107.
  • Sobrin L, Stanwyck LK, Pan W, Hubbard RA, Kempen JH, VanderBeek BL. Association of hypovitaminosis D with increased risk of uveitis in a large health care claims database. JAMA Ophthalmol. 2018 May 1;136(5):548–552. doi:10.1001/jamaophthalmol.2018.0642.
  • Grotting LA, Davoudi S, Palenzuela D, Papaliodis GN, Sobrin L. Association of low vitamin D levels with noninfectious anterior uveitis. JAMA Ophthalmol 2017 01;135(2):150–153. doi:10.1001/jamaophthalmol.2016.4888.
  • de Parisot A, Kodjikian L, Errera M-H, et al. Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol. 2017 Jun;178:176–185. doi:10.1016/j.ajo.2017.03.029.
  • Grumet P, Kodjikian L, de Parisot A, et al. Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis). Autoimmun Rev. 2018 Feb 7. doi:10.1016/j.autrev.2017.10.018.
  • Niederer RL, Al-Janabi A, Lightman SL, Tomkins-Netzer O. Serum angiotensin converting enzyme (ACE) has a high negative predictive value in the investigation for systemic sarcoidosis. Am J Ophthalmol. 2018 Jul 24. doi:10.1016/j.ajo.2018.07.010.
  • Baughman RP, Papanikolaou I. Current concepts regarding calcium metabolism and bone health in sarcoidosis. Curr Opin Pulm Med. 2017;23(5):476–481. doi:10.1097/MCP.0000000000000400.
  • Saidenberg-Kermanac’h N, Semerano L, Nunes H, et al. Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients. Arthritis Res Ther. 2014 Mar 24;16(2):R78. doi:10.1186/ar4519.
  • Kamphuis LS, Bonte-Mineur F, van Laar JA, van Hagen PM, van Daele PL. Calcium and vitamin D in sarcoidosis: is supplementation safe? J Bone Miner Res Off J Am Soc Bone Miner Res. 2014 Nov;29(11):2498–2503. doi:10.1002/jbmr.2262.
  • Capolongo G, Xu LHR, Accardo M, et al. Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis. J Investig Med Off Publ Am Fed Clin Res. 2016;64(5):1025–1034.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.